Orlando, FL -- (SBWIRE) -- 11/01/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Alpha Natural Resources, Inc. (NYSE:ANR), J.C. Penney Company, Inc.(NYSE:JCP).
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares plunged 44.44% to $2.20. The company on Oct. 31 said it is suspending sales of its leukemia drug Iclusig because of concerns that patients could suffer from blood clots. The company said that the Food and Drug Administration asked it to stop marketing the drug Wednesday afternoon. The company is negotiating with the FDA about changes to prescribing information and new ways to manage the risks associated with Iclusig. Ariad said it wants to resume marketing the drug.
Are investors worried about the recent updates with ARIA? Find out with a free trend analysis HERE
Alpha Natural Resources, Inc. (NYSE:ANR) shares increased 3.86% to $7. The company on Oct. 31 reported a third quarter 2013 net loss of $458 million or $2.07 per diluted share compared with a net loss of $46 million or $0.21 per diluted share in the third quarter of 2012. The third quarter 2013 adjusted net loss was $134 million or $0.61 per diluted share compared with adjusted net loss of $36 million or $0.16 per diluted share in the third quarter of 2012.
Additionally, research firm BMO Capital Markets on Oct. 18 downgraded ANR’s stock from Market Perform to Underperform.
Is ANR going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
J.C. Penney Company, Inc.(NYSE:JCP) shares dropped 1.32% to $7.50. Wolf Haldenstein Adler Freeman & Herz LLP on Oct. 23 announces that a class action lawsuit has been filed in the United States District Court, Eastern District of Texas, on behalf of all persons who purchased or otherwise acquired securities (including common stock, debt securities, call and put options) of J.C. Penney Co., Inc. ("J.C. Penney" or the "Company") (NYSE:JCP) between May 16, 2013 and September 26, 2013, inclusive (the "Class Period"), against the Company and certain of the Company's officers and directors ("Defendants"), alleging securities fraud pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [15 U.S.C. §§ 78j(b) and 78t(a)] and Rule 10b-5 promulgated thereunder by the SEC [17 C.F.R. § 240.10b-5].
Is JCP going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)